A detailed history of Bank Of America Corp transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 406,159 shares of RCKT stock, worth $5.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
406,159
Previous 1,238,044 67.19%
Holding current value
$5.3 Million
Previous $26.7 Million 71.86%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.6 - $25.88 $14.6 Million - $21.5 Million
-831,885 Reduced 67.19%
406,159 $7.5 Million
Q2 2024

Aug 14, 2024

BUY
$20.66 - $26.72 $4.54 Million - $5.87 Million
219,556 Added 21.56%
1,238,044 $26.7 Million
Q1 2024

May 15, 2024

BUY
$26.16 - $30.74 $5.88 Million - $6.91 Million
224,750 Added 28.32%
1,018,488 $27.4 Million
Q4 2023

Feb 14, 2024

BUY
$16.78 - $31.94 $6.07 Million - $11.6 Million
361,897 Added 83.8%
793,738 $23.8 Million
Q2 2023

Aug 14, 2023

SELL
$16.59 - $23.6 $3.07 Million - $4.37 Million
-185,316 Reduced 30.03%
431,841 $8.58 Million
Q1 2023

May 12, 2023

BUY
$15.79 - $22.6 $3.63 Million - $5.2 Million
229,982 Added 59.4%
617,157 $10.6 Million
Q4 2022

Feb 10, 2023

BUY
$15.5 - $22.76 $3.25 Million - $4.77 Million
209,792 Added 118.27%
387,175 $7.58 Million
Q3 2022

Nov 14, 2022

BUY
$12.37 - $18.41 $1.34 Million - $2 Million
108,474 Added 157.42%
177,383 $2.83 Million
Q2 2022

Aug 12, 2022

SELL
$7.96 - $16.64 $259,925 - $543,362
-32,654 Reduced 32.15%
68,909 $948,000
Q1 2022

May 16, 2022

SELL
$13.16 - $23.68 $10,264 - $18,470
-780 Reduced 0.76%
101,563 $1.61 Million
Q4 2021

Feb 08, 2022

SELL
$21.52 - $36.02 $2.06 Million - $3.44 Million
-95,624 Reduced 48.3%
102,343 $2.23 Million
Q3 2021

Nov 15, 2021

SELL
$27.42 - $48.97 $4.34 Million - $7.74 Million
-158,127 Reduced 44.41%
197,967 $5.92 Million
Q2 2021

Sep 13, 2021

BUY
$39.41 - $47.25 $14 Million - $16.8 Million
356,094 New
356,094 $15.8 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $987M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.